Ingles Pharmacy #070 - Medicare Supplier in Greeneville, TN

Ingles Pharmacy #070 is a medicare enrolled Community/Retail Pharmacy in Greeneville, Tennessee. It is located at 2845 E Andrew Johnson Hwy, Greeneville, Tennessee 37745. You can reach out to the office of Ingles Pharmacy #070 via phone at (423) 638-7021. Ingles Pharmacy #070 supplies medicare equipments and products such as Blood Glucose Monitors & Supplies: Non-Mail Order, etc. The legal business name for Ingles Pharmacy #070 is Ingles Markets Inc.

Contact Information

Ingles Pharmacy #070
2845 E Andrew Johnson Hwy, Greeneville, Tennessee 37745
(423) 638-7021


Supplier Profile

NameIngles Pharmacy #070
Organization NameIngles Markets Inc
Location2845 E Andrew Johnson Hwy, Greeneville, Tennessee 37745
TypeCommunity/Retail Pharmacy
Phone(423) 638-7021
Participate in MedicareMedicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier.

News Archive

China's SFDA approves Celsion's global Phase III ThermoDox HEAT trial for treating liver cancer

Celsion Corporation announced today that it has received official approval from China's State Food and Drug Administration ("SFDA") for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

KYTHERA presents long-term results from ATX-101 Phase 2 study at ASDS 2011

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.

Health reform politics still swirling; SEIU close to choosing new leader

CongressDaily: "When House Minority Leader Boehner ranks wholesale repeal of healthcare reform as Republicans' No. 1 priority, that thinking might be more wishful than pragmatic." If the GOP scores significant gains in the upcoming midterm and 2012 elections, they could draw Democrats back to the table to renegotiate certain parts of the law.

Read more Medical News

› Verified 4 days ago

Products, Equipments, Supplies available at this Supplier:

Ingles Pharmacy #070 supplies following medicare products, supplies and equipments -
  • Blood Glucose Monitors & Supplies: Non-Mail Order

NPI Associated with this Supplier:

Suppliers may have multiple NPI numbers. We have found possible NPI number/s associated with Ingles Pharmacy #070 from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1619333879
Organization NameINGLES MARKETS INC
Doing Business AsINGLES PHARMACY #070
TypeCommunity/Retail Pharmacy
Address2845 E Andrew Johnson Hwy, Greeneville, TN 37745
Phone Number423-638-7021

News Archive

China's SFDA approves Celsion's global Phase III ThermoDox HEAT trial for treating liver cancer

Celsion Corporation announced today that it has received official approval from China's State Food and Drug Administration ("SFDA") for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

KYTHERA presents long-term results from ATX-101 Phase 2 study at ASDS 2011

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.

Health reform politics still swirling; SEIU close to choosing new leader

CongressDaily: "When House Minority Leader Boehner ranks wholesale repeal of healthcare reform as Republicans' No. 1 priority, that thinking might be more wishful than pragmatic." If the GOP scores significant gains in the upcoming midterm and 2012 elections, they could draw Democrats back to the table to renegotiate certain parts of the law.

Read more Medical News

› Verified 4 days ago

News Archive

China's SFDA approves Celsion's global Phase III ThermoDox HEAT trial for treating liver cancer

Celsion Corporation announced today that it has received official approval from China's State Food and Drug Administration ("SFDA") for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).

MicroDose initiates Phase 1 clinical trial investigating the pharmacokinetics of atropine inhalation

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.

KYTHERA presents long-term results from ATX-101 Phase 2 study at ASDS 2011

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.

Health reform politics still swirling; SEIU close to choosing new leader

CongressDaily: "When House Minority Leader Boehner ranks wholesale repeal of healthcare reform as Republicans' No. 1 priority, that thinking might be more wishful than pragmatic." If the GOP scores significant gains in the upcoming midterm and 2012 elections, they could draw Democrats back to the table to renegotiate certain parts of the law.

Read more News

› Verified 4 days ago


Suppliers in Greeneville, TN

Atchley Drug Center
Type: Community/Retail Pharmacy
Location: 511 Asheville Hwy, Greeneville, Tennessee 37743
Phone: (423) 639-5155    
Bristol Orthotics & Prosthetics Inc
Type: Prosthetic/Orthotic Supplier
Location: 504 Justis Dr, Greeneville, Tennessee 37745
Phone: (423) 638-2670    
Central Drug Store
Type: Pharmacy
Location: 239 W Summer St, Greeneville, Tennessee 37743
Phone: (423) 638-4711    
East View Eye Care Pc
Type: Medicare Supplier
Location: 1000 Tusculum Blvd, Greeneville, Tennessee 37745
Phone: (423) 639-8128    
Greene County Drugstore Llc
Type: Community/Retail Pharmacy
Location: 906 Tusculum Blvd, Greeneville, Tennessee 37745
Phone: (423) 638-7101    

Medicare Suppliers

Durable Medical Equipment & Medical Supplies

Also referred to as DME Suppliers. A supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time.

Community/Retail Pharmacy

A pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers; administer vaccinations; and provide other professional services associated with pharmaceutical care.

Prosthetic/Orthotic Supplier

An organization that provides prosthetic and orthotic care which may include, but is not limited to, patient evaluation, prosthesis or orthosis design, fabrication, fitting and modification to treat limb loss for purposes of restoring physiological function and/or cosmesis or to treat a neuromusculoskeletal disorder or acquired condition.


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.